Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,481 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Metastatic clear-cell renal cell carcinoma: a frequent NOTCH1 mutation predictive of response to anti-NOTCH1 CB-103 treatment.
Bui TO, Angeli E, El Bouchtaoui M, Gapihan G, Dao VT, Paris J, Leboeuf C, Soussan M, Villarese P, Ziol M, Van Glabeke E, Le TH, Feugeas JP, Janin A, Bousquet G. Bui TO, et al. Among authors: paris j. Exp Hematol Oncol. 2023 May 15;12(1):46. doi: 10.1186/s40164-023-00408-z. Exp Hematol Oncol. 2023. PMID: 37189165 Free PMC article.
Increased risk of brain metastases among patients with melanoma and PROM2 expression in metastatic lymph nodes.
Nguyen TT, Gapihan G, Tetu P, Pamoukdjian F, El Bouchtaoui M, Lebœuf C, Feugeas JP, Paris J, Baroudjian B, Delyon J, Mourah S, Lebbé C, Janin A, Bousquet G, Battistella M. Nguyen TT, et al. Among authors: paris j. Clin Transl Med. 2020 Dec;10(8):e198. doi: 10.1002/ctm2.198. Clin Transl Med. 2020. PMID: 33377645 Free PMC article. No abstract available.
PROM2 overexpression induces metastatic potential through epithelial-to-mesenchymal transition and ferroptosis resistance in human cancers.
Paris J, Wilhelm C, Lebbé C, Elmallah M, Pamoukdjian F, Héraud A, Gapihan G, Walle AV, Tran VN, Hamdan D, Allayous C, Battistella M, Van Glabeke E, Lim KW, Leboeuf C, Roger S, Falgarone G, Phan AT, Bousquet G. Paris J, et al. Clin Transl Med. 2024 Mar;14(3):e1632. doi: 10.1002/ctm2.1632. Clin Transl Med. 2024. PMID: 38515278 Free PMC article.
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases.
Angeli E, Paris J, Le Tilly O, Desvignes C, Gapihan G, Boquet D, Pamoukdjian F, Hamdan D, Rigal M, Poirier F, Lutomski D, Azibani F, Mebazaa A, Herbet A, Mabondzo A, Falgarone G, Janin A, Paintaud G, Bousquet G. Angeli E, et al. Among authors: paris j. Exp Hematol Oncol. 2024 Apr 15;13(1):41. doi: 10.1186/s40164-024-00513-7. Exp Hematol Oncol. 2024. PMID: 38622749 Free PMC article.
How to deal with runaway metastatic disease?
Paris J, Bousquet G. Paris J, et al. Oncotarget. 2024 Jul 12;15:466-467. doi: 10.18632/oncotarget.28609. Oncotarget. 2024. PMID: 39007258 Free PMC article. No abstract available.
Correspondence.
Paris J, Macri C, Sia D, Chan WO. Paris J, et al. Retina. 2025 Jan 1;45(1):e3. doi: 10.1097/IAE.0000000000004291. Retina. 2025. PMID: 39699858 No abstract available.
1,481 results